Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Pancreatic Neoplasms 2Choledocholithiasis 2Vulvar Neoplasms 1Vulvar Diseases 1Uterine Cervical Dysplasia 1Papillomavirus Infections 1Pancreatitis 1Pain 1Choledochal Cyst 1Cholangitis 1Cholangiocarcinoma 1Carcinoma in Situ 1Agnosia 1

Interventions

Colposcopy 9Imiquimod 7Conization 7Papillomavirus Vaccines 6Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 6Cryotherapy 6human papillomavirus vaccine, L1 type 16, 18 4Blood Specimen Collection 4Vaginal Smears 3Vaccines 3Papanicolaou Test 3VGX-3100 2Topotecan 2Proflavine 2Polymerase Chain Reaction 2Paclitaxel 2Mass Screening 2Human Papillomavirus DNA Tests 2Fluorouracil 2Cisplatin 2Biopsy 2Acetic Acid 24,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone 2terameprocol 1poly(gamma-glutamic acid) 1methyl 5-aminolevulinate 1lime 1human papillomavirus vaccine, TA 1hecolin 1fludarabine phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Uterine Cervical Dysplasia × Meperidine × Clear all
NCT02858310 2026-03-09

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
224 enrolled 15 charts
Gynecologic

Carcinoma in Situ, Uterine Cervical Dysplasia, Vulvar Diseases, Vulvar Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡